Affiliation:
1. Advanced Center for Genome Technology, University of Oklahoma, Norman, Oklahoma 73019
2. Department of Chemistry, Southeastern Oklahoma State University, Durant, Oklahoma 74701
3. Department of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island 02881
Abstract
ABSTRACT
The carbon sources that support the growth of pathogenic
Escherichia coli
O157:H7 in the mammalian intestine have not previously been investigated. In vivo, the pathogenic
E. coli
EDL933 grows primarily as single cells dispersed within the mucus layer that overlies the mouse cecal epithelium. We therefore compared the pathogenic strain and the commensal
E. coli
strain MG1655 modes of metabolism in vitro, using a mixture of the sugars known to be present in cecal mucus, and found that the two strains used the 13 sugars in a similar order and cometabolized as many as 9 sugars at a time. We conducted systematic mutation analyses of
E. coli
EDL933 and
E. coli
MG1655 by using lesions in the pathways used for catabolism of 13 mucus-derived sugars and five other compounds for which the corresponding bacterial gene system was induced in the transcriptome of cells grown on cecal mucus. Each of 18 catabolic mutants in both bacterial genetic backgrounds was fed to streptomycin-treated mice, together with the respective wild-type parent strain, and their colonization was monitored by fecal plate counts. None of the mutations corresponding to the five compounds not found in mucosal polysaccharides resulted in colonization defects. Based on the mutations that caused colonization defects, we determined that both
E. coli
EDL933 and
E. coli
MG1655 used arabinose, fucose, and
N
-acetylglucosamine in the intestine. In addition,
E. coli
EDL933 used galactose, hexuronates, mannose, and ribose, whereas
E. coli
MG1655 used gluconate and
N
-acetylneuraminic acid. The colonization defects of six catabolic lesions were found to be additive with
E. coli
EDL933 but not with
E. coli
MG1655. The data indicate that pathogenic
E. coli
EDL933 uses sugars that are not used by commensal
E. coli
MG1655 to colonize the mouse intestine. The results suggest a strategy whereby invading pathogens gain advantage by simultaneously consuming several sugars that may be available because they are not consumed by the commensal intestinal microbiota.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Cited by
328 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献